OncoGenex Pharmaceuticals Company Profile (NASDAQ:OGXI)

About OncoGenex Pharmaceuticals

OncoGenex Pharmaceuticals logoOncoGenex Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company engaged in the development and commercialization of therapies that address treatment resistance in cancer patients. The Company's segment is dedicated to the development and commercialization of cancer therapies, with operations located in Canada and the United States. The Company's product candidates include Custirsen, Apatorsen and OGX-225. The Company is focused on targeting these particular proteins to disable the tumor cell's adaptive defenses, thereby rendering the tumor cells susceptible to attack with a range of cancer therapies. Of these product candidates, Custirsen and Apatorsen are clinical-stage assets. Custirsen is being evaluated in two Phase III trials. Apatorsen is a product candidate designed to inhibit production of heat shock protein 27 (Hsp27). OGX-225 is a product candidate designed to inhibit the production of Insulin Growth Factor Binding Proteins-2 and -5 (IGFBP-2, IGFBP-5).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: OGXI
  • CUSIP: 68230A10
Key Metrics:
  • Previous Close: $0.46
  • 50 Day Moving Average: $0.436
  • 200 Day Moving Average: $0.689
  • 52-Week Range: $0.33 - $1.42
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.53
  • P/E Growth: 0.000
  • Market Cap: $13.93M
  • Outstanding Shares: 30,020,000
  • Beta: 1.86
Profitability:
  • Net Margins: -94.64%
  • Return on Equity: -50.34%
  • Return on Assets: -33.95%
Debt:
  • Current Ratio: 3.24%
  • Quick Ratio: 3.24%
Additional Links:
Companies Related to OncoGenex Pharmaceuticals:

Analyst Ratings

Consensus Ratings for OncoGenex Pharmaceuticals (NASDAQ:OGXI) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $2.00 (331.03% upside)

Analysts' Ratings History for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
Show:
DateFirmActionRatingPrice TargetDetails
1/22/2016Needham & Company LLCLower Price TargetBuy$6.00 -> $3.00View Rating Details
1/21/2016Royal Bank Of CanadaLower Price TargetSector Perform$1.60 -> $1.00View Rating Details
12/2/2015Stifel NicolausDowngradeBuy -> HoldView Rating Details
9/24/2015William BlairReiterated RatingBuy$6.00View Rating Details
(Data available from 12/8/2014 forward)

Earnings

Earnings History for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/7/2017        
11/10/2016Q316($0.26)($0.12)ViewN/AView Earnings Details
8/4/2016Q216($0.22)($0.23)$1.17 million$2.10 millionViewN/AView Earnings Details
5/12/2016Q116($0.12)($0.12)$4.09 million$2.90 millionViewListenView Earnings Details
3/9/2016Q4($0.15)($0.06)ViewN/AView Earnings Details
11/12/2015Q3($0.17)($0.16)ViewListenView Earnings Details
8/13/2015Q2$0.34($0.26)ViewListenView Earnings Details
5/14/2015Q115($0.34)($0.20)$4.66 million$1.40 millionViewListenView Earnings Details
3/26/2015Q414($0.30)($0.27)$4.30 million$5.70 millionViewN/AView Earnings Details
10/30/2014($0.38)($0.23)ViewN/AView Earnings Details
8/7/2014($0.55)($0.47)ViewN/AView Earnings Details
4/30/2014($0.50)($0.59)ViewN/AView Earnings Details
3/11/2014Q113($0.66)($0.45)$10.20 million$8.60 millionViewN/AView Earnings Details
11/8/2012Q312($0.49)($0.40)$4.52 million$6.57 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
Current Year EPS Consensus Estimate: $-0.820 EPS
Next Year EPS Consensus Estimate: $-0.880 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.07)($0.07)($0.07)
Q2 20161($0.27)($0.27)($0.27)
Q3 20161($0.28)($0.28)($0.28)
Q4 20161($0.28)($0.28)($0.28)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
Insider Ownership Percentage: 3.30%
Institutional Ownership Percentage: 18.54%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/19/2016John BencichCFOSell1,380$0.57$786.60View SEC Filing  
6/13/2016Cindy JacobsCMOSell1,437$1.03$1,480.11View SEC Filing  
6/13/2016Scott Daniel CormackCEOSell4,856$1.03$5,001.68View SEC Filing  
3/15/2016Cindy JacobsCMOSell3,254$0.83$2,700.82View SEC Filing  
3/15/2016John BencichCFOSell834$0.83$692.22View SEC Filing  
3/15/2016Scott Daniel CormackCEOSell12,033$0.83$9,987.39View SEC Filing  
8/18/2015John BencichCFOSell1,427$2.76$3,938.52View SEC Filing  
6/12/2015Cindy JacobsCMOSell1,408$2.69$3,787.52View SEC Filing  
6/12/2015Scott Daniel CormackCEOSell4,571$2.69$12,295.99View SEC Filing  
5/20/2015Cindy JacobsCMOSell2,092$1.88$3,932.96View SEC Filing  
5/20/2015Scott Daniel CormackCEOSell7,543$1.88$14,180.84View SEC Filing  
8/13/2014Cindy JacobsCMOSell5,650$3.17$17,910.50View SEC Filing  
8/13/2014Scott Daniel CormackCEOSell18,341$3.17$58,140.97View SEC Filing  
3/17/2014Cindy JacobsCMOSell1,250$12.25$15,312.50View SEC Filing  
3/17/2014Scott Daniel CormackCEOSell4,634$12.25$56,766.50View SEC Filing  
8/19/2013Cindy JacobsCMOSell1,364$8.68$11,839.52View SEC Filing  
8/19/2013Scott Daniel CormackCEOSell3,112$8.68$27,012.16View SEC Filing  
3/12/2013Scott Daniel CormackCEOSell2,134$11.90$25,394.60View SEC Filing  
8/15/2012Jack GoldsteinDirectorBuy1,000$14.38$14,380.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
DateHeadline
News IconMarket Center: Watching the Levels for OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Wall Street Beacon (NASDAQ:OGXI)
wsbeacon.com - December 7 at 11:58 PM
News IconEquity Check-in on Shares of OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Business Daily Leader (NASDAQ:OGXI)
businessdailyleader.com - December 6 at 6:44 PM
News IconWatching the Numbers for OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Wall Street Beacon (NASDAQ:OGXI)
wsbeacon.com - December 5 at 6:58 PM
News IconThis Weeks Target Prices For OncoGenex Pharmaceuticals Inc ... - NewsDen (NASDAQ:OGXI)
newsden.net - December 3 at 6:10 PM
News IconStock Check on OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Business Daily Leader (NASDAQ:OGXI)
businessdailyleader.com - December 2 at 6:42 PM
News IconROIC in Review for OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Business Daily Leader (NASDAQ:OGXI)
businessdailyleader.com - December 1 at 9:02 AM
finance.yahoo.com logoONCOGENEX PHARMACEUTICALS, INC. Financials (NASDAQ:OGXI)
finance.yahoo.com - November 30 at 7:07 PM
News IconPenny Stock Spotlight: Focusing on OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Duncan Research (NASDAQ:OGXI)
www.duncanindependent.com - November 23 at 6:43 PM
News IconTechnical Investors are Checking in on Shares of OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 23 at 9:49 AM
News IconWonder Stock Alert: Investors Curious About OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Duncan Research (NASDAQ:OGXI)
www.duncanindependent.com - November 23 at 9:49 AM
News IconPenny Stock Focus: Narrowing the Lens On OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Duncan Research (NASDAQ:OGXI)
www.duncanindependent.com - November 19 at 6:44 PM
News IconChart Focus: Eye on Technicals for OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 18 at 9:49 AM
News IconPenny Stock Making Waves: Taking a Second Look at OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Duncan Research (NASDAQ:OGXI)
www.duncanindependent.com - November 18 at 9:49 AM
News IconBroker Review: OncoGenex Pharmaceuticals Inc. (OGXI) - UK ... - UK Market News (NASDAQ:OGXI)
www.ukmarketnews.co.uk - November 17 at 10:32 AM
News IconRange Watch on Technical Indicators for OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 14 at 6:55 PM
News IconIndicator Review on Shares of OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 11 at 6:23 PM
News IconPenny Stock News: Looking Closer At OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Duncan Research (NASDAQ:OGXI)
www.duncanindependent.com - November 11 at 6:23 PM
News IconInvesting Focus: Indicators in View on Shares of OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 10 at 6:26 PM
News IconPenny Stock Interest: Checking In On OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Duncan Research (NASDAQ:OGXI)
www.duncanindependent.com - November 10 at 6:26 PM
biz.yahoo.com logoONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statemen (NASDAQ:OGXI)
biz.yahoo.com - November 10 at 6:26 PM
publicnow.com logoOncoGenex Pharmaceuticals, Inc. Reports Financial Results for Third Quarter 2016 (NASDAQ:OGXI)
www.publicnow.com - November 10 at 6:26 PM
seekingalpha.com logoOncoGenex Pharmaceuticals beats by $0.14 (NASDAQ:OGXI)
seekingalpha.com - November 10 at 4:41 PM
News IconTale of the Tape: Technical Recap for OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 10 at 9:41 AM
biz.yahoo.com logoQ3 2016 OncoGenex Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:OGXI)
biz.yahoo.com - November 10 at 9:41 AM
News IconQuick Review on Trend Indicator Levels: OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 8 at 6:19 PM
News IconKey Technicals Update on OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - StockTalk Daily (NASDAQ:OGXI)
stocktalkdaily.com - November 7 at 7:19 PM
News IconTechnical Levels in Review for OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 7 at 7:19 PM
News IconEquity Rundown: RSI and CCI Check on OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 4 at 6:07 PM
News IconRSI, CCI, and ADX Levels in View for OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 4 at 10:11 AM
News IconPenny Stock in the News: Focusing In On OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Duncan Research (NASDAQ:OGXI)
www.duncanindependent.com - November 4 at 10:11 AM
live-pr.com logoNow Available: Oncogenex Pharmaceuticals, Inc. (OGXI) - Financial and Strategic SWOT Analysis Review (NASDAQ:OGXI)
www.live-pr.com - November 3 at 6:41 PM
publicnow.com logoOncoGenex to Report Third Quarter 2016 Financial Results on Nov. 10, 2016 (NASDAQ:OGXI)
www.publicnow.com - November 3 at 6:41 PM
News IconTraders are Keeping Track of Technicals on Shares of OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 2 at 6:55 PM
News IconNewsmaking Penny Stock: Update on OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Duncan Research (NASDAQ:OGXI)
www.duncanindependent.com - November 2 at 6:55 PM
News IconLooking at the Technicals for OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - November 2 at 10:09 AM
News IconNewsworthy Penny Stock: Investors Checking In On OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Duncan Research (NASDAQ:OGXI)
www.duncanindependent.com - November 2 at 10:09 AM
News IconPenny Stock in the News: Checking in on OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Duncan Research (NASDAQ:OGXI)
www.duncanindependent.com - October 31 at 6:27 PM
News IconIndicator Level Summary for OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - October 31 at 12:31 PM
streetinsider.com logoOncoGenex Pharma (OGXI) to Cut Workforce by 55% (NASDAQ:OGXI)
www.streetinsider.com - October 28 at 6:23 PM
biz.yahoo.com logoONCOGENEX PHARMACEUTICALS, INC. Files SEC form 8-K, Costs Associated with Exit or Disposal Activities (NASDAQ:OGXI)
biz.yahoo.com - October 28 at 6:23 PM
News IconDipexium Pharmaceuticals Inc (DPRX) is Downgraded by Raymond James to Mkt Perform (NASDAQ:OGXI)
crcconnection.com - October 28 at 10:19 AM
News IconRSI Update on Shares of OncoGenex Pharmaceuticals Inc. (OGXI) - MicroCap Wired (NASDAQ:OGXI)
www.microcapwired.com - October 27 at 11:30 AM
istreetwire.com logoMomentum Stocks in Focus: OncoGenex Pharmaceuticals, Inc. (OGXI) Facebook, Inc. (FB) Cliffs Natural Resources Inc ... - iStreetWire (NASDAQ:OGXI)
istreetwire.com - October 27 at 11:30 AM
News IconMaking News: Update on Penny Stock OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) - Duncan Research (NASDAQ:OGXI)
www.duncanindependent.com - October 27 at 11:30 AM
streetinsider.com logoOncoGenex Pharma (OGXI) Announces Strong Survival Data from Apatorsen Phase 2 in MBC - StreetInsider.com (NASDAQ:OGXI)
www.streetinsider.com - October 27 at 11:30 AM
News IconLeading Stock of Yesterday- OncoGenex Pharmaceuticals Inc. (NASDAQ:OGXI) - Hot Stocks Point (NASDAQ:OGXI)
www.hotstockspoint.com - October 27 at 11:30 AM
News IconCompany ‘put into impossible position’ after main bank account at AIB frozen (NASDAQ:OGXI)
www.ad-hoc-news.de - October 26 at 6:39 PM
streetinsider.com logoOncoGenex Pharma (OGXI) Announces Strong Survival Data from Apatorsen Phase 2 in MBC (NASDAQ:OGXI)
www.streetinsider.com - October 26 at 6:39 PM

Social

OncoGenex Pharmaceuticals (NASDAQ:OGXI) Chart for Thursday, December, 8, 2016


Last Updated on 12/8/2016 by MarketBeat.com Staff